VEGFA and decubitus ulcer: We previously demonstrated that SHED-CM has potent therapeutic effects in a mouse model of the formation of pressure ulcer induced by cutaneous ischemia–reperfusion injury, which highly depend on antioxidative and angiogenic activities, mainly via HGF and VEGF [25].